2.84
price down icon12.35%   -0.40
after-market Handel nachbörslich: 2.73 -0.11 -3.87%
loading

Genprex Inc Aktie (GNPX) Neueste Nachrichten

pulisher
Dec 08, 2025

MSN Money - MSN

Dec 08, 2025
pulisher
Dec 05, 2025

Genprex Inc Stock Analysis and ForecastSector-Based Investing & High Yield Market Growth - earlytimes.in

Dec 05, 2025
pulisher
Dec 05, 2025

Will Genprex Inc. (2DE0) stock recover faster than industry2025 Analyst Calls & Risk Managed Investment Signals - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Genprex Inc. (2DE0) stock undervalued after correctionJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Genprex Inc. stock cheap at current valuationWeekly Profit Report & Community Driven Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of - Benzinga

Dec 04, 2025
pulisher
Dec 04, 2025

Can Genprex Inc. (2DE0) stock reach $200 price targetEarnings Growth Summary & Entry and Exit Point Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Get in on Genprex Inc’s (GNPX) buy-in window today! - setenews.com

Dec 04, 2025
pulisher
Dec 04, 2025

Why Genprex Inc. stock remains on buy listsWeekly Profit Summary & Fast Gaining Stock Reports - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Genprex, Inc. Stock (GNPX) Opinions on Recent Preclinical Data Release - Quiver Quantitative

Dec 03, 2025
pulisher
Dec 03, 2025

Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules - Aktiellt

Dec 03, 2025
pulisher
Dec 02, 2025

Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules - Aktiellt

Dec 02, 2025
pulisher
Dec 02, 2025

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire) - Aktiellt

Dec 02, 2025
pulisher
Nov 30, 2025

Can Genprex Inc. stock beat market expectations this quarterMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 27, 2025

Taking the lead: Genprex Inc (GNPX) - Setenews

Nov 27, 2025
pulisher
Nov 27, 2025

How Genprex Inc. (2DE0) stock reacts to new regulations2025 Market Trends & Daily Volume Surge Signals - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

Genprex regains Nasdaq bid price compliance, receives equity extension By Investing.com - Investing.com Australia

Nov 26, 2025
pulisher
Nov 26, 2025

Genprex regains Nasdaq bid price compliance, receives equity extension - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

Genprex keeps Nasdaq listing with bid-price fix, equity waiver granted - Stock Titan

Nov 26, 2025
pulisher
Nov 24, 2025

Genprex reports phase 1 data for lung cancer gene therapy By Investing.com - Investing.com Nigeria

Nov 24, 2025
pulisher
Nov 24, 2025

Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Tria - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Genprex (GNPX) Shares Positive Acclaim-1 Trial Data for Lung Can - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Genprex reports phase 1 data for lung cancer gene therapy - Investing.com

Nov 24, 2025
pulisher
Nov 24, 2025

Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer - PR Newswire

Nov 24, 2025
pulisher
Nov 22, 2025

Genprex files prospectus supplement for up to $75 million at-the-market offering By Investing.com - Investing.com Australia

Nov 22, 2025
pulisher
Nov 22, 2025

Genprex files prospectus supplement for up to $75 million at-the-market offering - Investing.com Australia

Nov 22, 2025
pulisher
Nov 22, 2025

Genprex Inc. (GNPX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 22, 2025
pulisher
Nov 21, 2025

Genprex Announces $75 Million Stock Offering - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

[S-1] Genprex, Inc. Files IPO Registration Statement | GNPX SEC FilingForm S-1 - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Genprex, Inc. Announces $75 Million Stock Offering - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] Genprex, Inc. Reports Material Event | GNPX SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Can Genprex Inc. (2DE0) stock sustain revenue momentumWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Genprex Inc. stock benefits from tech adoption2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Genprex Inc. stock attractive for retirement portfoliosJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why Genprex Inc. (2DE0) stock attracts wealthy investorsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Genprex Inc. (2DE0) stock at risk of policy regulationWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Genprex Inc. (2DE0) stock outperform global peersJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 22:26:30 - newser.com

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):